PARI provides comprehensive analytical services for product development in combination with nebuliser customisation from early phase to submission and commercialisation.

Long-Term Supply & Consistent Quality

for Your Commercial Success

 

Establishing your breakthrough therapy needs an efficient, high-quality nebulizer. With two production facilities in Germany, we guarantee scalable manufacturing, timely delivery and longterm availability – from clinical trial devices to full-scale commercial supply.

Expert Interview: Commercialization stage

Matthias Brosig, Director eFlow Alliance Operations, shares insights how we transmit drug-nebulizer combination products efficiently from development to commercial stage while supporting your market access activities.

How You Benefit from Partnering with Us

    • 20+ years of expertise in mesh nebulizer development and sustainable partnerships for your success
    • German engineering and rigorous quality control, backed by ISO 13485 certification and regular audits
    • Consistent high quality with automated manufacturing and in-process control for every component and device
    • Seamless transition from small-batch production to global commercialization
    • Secure supply chain with efficient management for reliable, on-time delivery           
    Highly automated mesh manufacturing capabilities
    Highly automated mesh manufacturing capabilities.

    Secure a reliable device supply for your breakthrough therapy!

    eFlow-partneringpari.com

    Two smiling men in a blue circle. The central man wears glasses and a light blue shirt. The man on the left has a beard and a blue patterned shirt.

    PARI Business Development Team